fexofenadine has been researched along with Allergic Reaction in 21 studies
fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the effect of fexofenadine on extensive alopecia areata (AA), we evaluated retrospectively 121 patients with AA having alopecia in more than 50% of the scalp and followed them for at least 6 months." | 7.75 | Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases. ( Inui, S; Itami, S; Nakajima, T; Toda, N, 2009) |
| "High incidence of allergy in ASD patients may indicate immune dysregulation that could be of relevance to the pathophysiology, symptomatology or neuroimmunology of ASD." | 5.51 | A novel concept of immunological and allergy interactions in autism spectrum disorders: Molecular, anti-inflammatory effect of osthole. ( Chwała, B; Cieślińska, A; Fiedorowicz, E; Jarmołowska, B; Kordulewska, NK; Kostyra, E; Moszyńska, M, 2019) |
| " and intracerebroventricular pentobarbital-induced sedation and alcohol-induced ataxia models." | 3.76 | Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H. ( Bagad, AS; Bahekar, PC; Chidrewar, GU; Mandhane, SN; Mehetre, SV; Pawar, CA; Rajamannar, T; Rao, CT; Shah, JH, 2010) |
| "To study the effect of fexofenadine on extensive alopecia areata (AA), we evaluated retrospectively 121 patients with AA having alopecia in more than 50% of the scalp and followed them for at least 6 months." | 3.75 | Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases. ( Inui, S; Itami, S; Nakajima, T; Toda, N, 2009) |
| "In vivo antihistaminic activity experiments consisted of measurement of: inhibition of increase in capillary permeability and reduction in microvascular extravasation and bronchospasm in rats and guinea pigs induced by histamine and other inflammatory mediators; and protection against lethality induced by histamine and other inflammatory mediators in rats." | 3.73 | In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist. ( Berisa, A; Corcóstegui, R; Innerárity, A; Labeaga, L; Orjales, A, 2006) |
| "Fexofenadine is safe and efficacious at single doses of 60 mg and 120 mg." | 2.68 | Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit. ( Briscoe, MP; Clark, A; Day, JH; Ellis, AK; Mason, J; Smith, JN; Welsh, A, 1997) |
| "Fexofenadine is a nonsedating, long-acting antihistamine with highly selective H(1)-receptor antagonist activity and a particularly favorable safety profile." | 2.42 | Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules. ( Canonica, GW; Ciprandi, G; Cosentino, C; Passalacqua, G; Riccio, AM; Tosca, MA, 2003) |
| "High incidence of allergy in ASD patients may indicate immune dysregulation that could be of relevance to the pathophysiology, symptomatology or neuroimmunology of ASD." | 1.51 | A novel concept of immunological and allergy interactions in autism spectrum disorders: Molecular, anti-inflammatory effect of osthole. ( Chwała, B; Cieślińska, A; Fiedorowicz, E; Jarmołowska, B; Kordulewska, NK; Kostyra, E; Moszyńska, M, 2019) |
| "Fexofenadine (FXF) is a third-generation antihistamine drug and osthole is assumed as a natural antihistamine alternative." | 1.46 | Changes in gene expression induced by histamine, fexofenadine and osthole: Expression of histamine H ( Cieślińska, A; Fiedorowicz, E; Kordulewska, NK; Kostyra, E; Matysiewicz, M; Sienkiewicz-Szłapka, E, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 12 (57.14) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kordulewska, N | 1 |
| Cieślińska, A | 4 |
| Fiedorowicz, E | 4 |
| Jarmołowska, B | 3 |
| Kostyra, E | 4 |
| Kordulewska, NK | 3 |
| Chwała, B | 1 |
| Moszyńska, M | 1 |
| Matysiewicz, M | 1 |
| Sienkiewicz-Szłapka, E | 1 |
| Inui, S | 1 |
| Nakajima, T | 1 |
| Toda, N | 1 |
| Itami, S | 1 |
| Smith, SM | 1 |
| Gums, JG | 1 |
| Mandhane, SN | 1 |
| Shah, JH | 1 |
| Bahekar, PC | 1 |
| Mehetre, SV | 1 |
| Pawar, CA | 1 |
| Bagad, AS | 1 |
| Chidrewar, GU | 1 |
| Rao, CT | 1 |
| Rajamannar, T | 1 |
| Duchateau, J | 1 |
| Heenen, M | 1 |
| Sternon, J | 1 |
| Grzelewska-Rzymowska, I | 1 |
| Ciprandi, G | 1 |
| Tosca, MA | 1 |
| Cosentino, C | 1 |
| Riccio, AM | 1 |
| Passalacqua, G | 1 |
| Canonica, GW | 1 |
| Ruëff, F | 1 |
| Przybilla, B | 1 |
| Corcóstegui, R | 1 |
| Labeaga, L | 1 |
| Innerárity, A | 1 |
| Berisa, A | 1 |
| Orjales, A | 1 |
| Camelo-Nunes, IC | 1 |
| Asano, K | 1 |
| Kanai, K | 1 |
| Furuta, A | 1 |
| Furuya, A | 1 |
| Suzaki, H | 1 |
| Hisamitsu, T | 1 |
| Merk, HF | 1 |
| Day, JH | 1 |
| Briscoe, MP | 1 |
| Welsh, A | 1 |
| Smith, JN | 1 |
| Clark, A | 1 |
| Ellis, AK | 1 |
| Mason, J | 1 |
| Abdelaziz, MM | 1 |
| Khair, OA | 1 |
| Devalia, JL | 1 |
| Fridliand, DG | 1 |
| Gushchin, IS | 1 |
| Poroshina, IuA | 1 |
| Shul'zhenko, AE | 1 |
6 reviews available for fexofenadine and Allergic Reaction
| Article | Year |
|---|---|
Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders.
Topics: Animals; Anti-Allergic Agents; Clinical Trials as Topic; Humans; Hypersensitivity; Terfenadine | 2009 |
[H1 histamine antagonists].
Topics: Acetates; Anti-Allergic Agents; Cetirizine; Chemistry, Pharmaceutical; Histamine H1 Antagonists; Hum | 2003 |
[Clinical aspects of anti-inflammatory action of antihistamines].
Topics: Cetirizine; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivi | 2003 |
Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules.
Topics: Anti-Allergic Agents; Cell Adhesion Molecules; Histamine H1 Antagonists; Humans; Hypersensitivity; L | 2003 |
Venom immunotherapy: adverse reactions and treatment failure.
Topics: Histamine H1 Antagonists; Humans; Hypersensitivity; Immunotherapy; Risk Factors; Terfenadine; Treatm | 2004 |
New antihistamines: a critical view.
Topics: Anti-Allergic Agents; Blood-Brain Barrier; Central Nervous System Diseases; Cetirizine; Child; Cypro | 2006 |
1 trial available for fexofenadine and Allergic Reaction
| Article | Year |
|---|---|
Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit.
Topics: Adolescent; Adult; Aged; Child; Double-Blind Method; Environmental Exposure; Female; Histamine Antag | 1997 |
14 other studies available for fexofenadine and Allergic Reaction
| Article | Year |
|---|---|
Effect of the Fexofenadine on the expression of HRH-1 and HRH-4 receptor in Peripheral Blood Mononuclear Cell isolated from children with diagnosed allergy - in vitro study Short communication.
Topics: Anti-Allergic Agents; Cells, Cultured; Child; Child, Preschool; Female; Gene Expression Regulation; | 2019 |
A novel concept of immunological and allergy interactions in autism spectrum disorders: Molecular, anti-inflammatory effect of osthole.
Topics: Anti-Inflammatory Agents; Autism Spectrum Disorder; Child; Child, Preschool; Coumarins; Cyclooxygena | 2019 |
Cytokine production by PBMC and serum from allergic and non-allergic subjects following in vitro histamine stimulation to test fexofenadine and osthole anti-allergic properties.
Topics: Adult; Anti-Allergic Agents; Coumarins; Cytokines; Histamine; Humans; Hypersensitivity; Immunoglobul | 2016 |
Changes in gene expression induced by histamine, fexofenadine and osthole: Expression of histamine H
Topics: Adult; Case-Control Studies; Chemokine CCL5; Coumarins; Cyclooxygenase 2; Female; Gene Expression Re | 2017 |
Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Cyclobuta | 2009 |
Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.
Topics: Acetates; Alcohols; Anaphylaxis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ataxia; Cetirizin | 2010 |
In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.
Topics: Animals; Benzimidazoles; Bradykinin; Bronchial Spasm; Capillary Permeability; Cetirizine; Dermatitis | 2006 |
Suppressive activity of fexofenadine hydrochloride on nitric oxide production in-vitro and in-vivo.
Topics: Administration, Oral; Animals; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; | 2007 |
[Introduction of a new antihistamine generation].
Topics: Histamine Antagonists; Histamine H1 Antagonists; Humans; Hypersensitivity; Hypersensitivity, Immedia | 1997 |
[Drug side effects and their prevention].
Topics: Arrhythmias, Cardiac; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Ele | 1997 |
[Fexofenadine--progress in antihistamine therapy].
Topics: Histamine H1 Antagonists; Humans; Hypersensitivity; Hypersensitivity, Immediate; Terfenadine | 1997 |
The potential of active metabolites of antihistamines in the management of allergic disease.
Topics: Anti-Inflammatory Agents; Butyrophenones; Cells, Cultured; Cetirizine; Chymases; Eosinophils; Granul | 2000 |
Newer antihistamines.
Topics: Administration, Oral; Anti-Allergic Agents; Cetirizine; Chlorpheniramine; Conscious Sedation; Diphen | 2001 |
[Comparative antihistamine and anti-allergic effects of various antihistamine preparations].
Topics: Adult; Anti-Allergic Agents; Butyrophenones; Cetirizine; Clemastine; Female; Histamine H1 Antagonist | 2002 |